The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate-Reference-Cited by-同舟云学术

The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate

Published:2016-12-01 Issue:2 Volume:390 Page:197-205
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Said Mahmoud M.,Bosland Maarten C.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-016-1325-4.pdf

Reference33 articles.

1. Abdel-Raheem IT, Khedr NF (2014) Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. N-S Arch Pharmacol 387:341–353

2. Chibana K, Ishii Y, Asakura T, Fukuda T (2003) Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J Immunol 170:4290–4295

3. Cowin PA, Foster P, Pedersen J, Hedwards S, McPherson SJ, Risbridger GP (2008) Early-onset endocrine disruptor-induced prostatitis in the rat. Environ Health Perspect 116:923–929

4. Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interf Cytokine Res 29:313–326

5. Ellem SJ, Wang H, Poutanen M, Risbridger GP (2009) Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 175:1187–1199

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EFFECT OF MONTELUKAST ON HEALING OF INDUCED ORAL ULCER IN RATS;Military Medical Science Letters;2023-12-01

2. Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats;Frontiers in Immunology;2022-09-06

3. Chlorogenic acid attenuates inflammation in LPS-induced Human gingival fibroblasts via CysLT1R/Nrf2/NLRP3 signaling;International Immunopharmacology;2022-06

4. The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial;European Journal of Pharmacology;2021-09

5. Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage;Inflammation Research;2021-08-11